Mgo One Seven LLC Geron Corp Transaction History

Mgo One Seven LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.75 - $3.44 $12,600 - $24,768	-7,200 Reduced 27.42%	19,060 $62,000
Q2 2023 Aug 11, 2023	BUY	$1.97 - $3.69 $32,032 - $59,999	16,260 Added 162.6%	26,260 $84,000
Q2 2020 Aug 12, 2020	BUY	$1.05 - $2.18 $10,500 - $21,800	10,000 New	10,000 $22,000
Q1 2019 Apr 09, 2019	SELL	$1.01 - $1.83 $5,050 - $9,150	-5,000 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$0.98 - $1.85 $4,900 - $9,250	5,000 New	5,000 $5,000
Q3 2018 Oct 09, 2018	SELL	$1.76 - $6.38 $225 - $816	-128 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$1.8 - $2.32 $230 - $296	128	128 $0

281

492M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.11B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.